Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Sumit K. Subudhi, Bilal A. Siddiqui, Ana M. Aparicio, Shalini S. Yadav, Sreyashi Basu, Hong Chen, Sonali Jindal, Rebecca S.S. Tidwell, Ashwin Varma, Christopher J. Logothetis, James P. Allison, Paul G. Corn, Padmanee Sharma

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment'. Together they form a unique fingerprint.

Medicine & Life Sciences